Effective testing, treatment and vaccines represent three key components of the health care industry’s response to COVID-19. As the pandemic surges across much of the country, new rapid testing and treatment innovations could help turn the tables on the virus.
COVID-19 vaccines are advancing through development with unprecedented speed and several are in the final stages of clinical trials. To help members keep up with clinical development efforts, Vizient launched a COVID-19 vaccine resource center, offering insights, tools, and the latest information on the development of COVID-19 vaccines.
The perceptions of patients regarding the safety of elective procedures has steadily improved since May, as shown in Vizient’s updated report Connecting With Patients During COVID-19. However, this has not translated into increased utilization of health care services.
This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.